医薬品の評価

Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal

Giovanni Barosi

• 抽象的な

レビュー: 臨床試験の結果

Implementation of strategic management tools improves wound care clinical trial outcomes

Marina Malikova, Lauren Shifflett & Alik Farber

• 抽象的な

医薬品の評価

Nintedanib: a new treatment for idiopathic pulmonary fibrosis

Vincent Cottin

• 抽象的な

レビュー: 臨床試験の結果

Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial

Changhoon Yoo & Yoon-Koo Kang

• 抽象的な

医薬品の評価

Linaclotide for irritable bowel syndrome with constipation: a review

Michael Arriaga & Eamonn MM Quigley

• 抽象的な